Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: jayhawk969 who wrote (23362)	7/19/1998 10:08:00 PM
From: tonyt	Respond to of 32384

>t is interesting that Rich Harmon bought in the money November LGND Calls as a >result of the rumor that their would be an article in Science regarding small molecule >mimics of poly-peptide drugs, and that this breakthrough alone had huge potential. When is this article coming out? LGND could use a boost.

To: jayhawk969 who wrote (23362)	7/19/1998 11:53:00 PM
From: Henry Niman	Respond to of 32384

Looks like DrownAtLakeLigand was busy on Yahoo! earlier, so some sane conversation could take place here. Looks like he just shifted boards and IDs :-).

To: jayhawk969 who wrote (23362)	7/19/1998 11:57:00 PM
From: Henry Niman	Respond to of 32384

The Science article was quite amazing. The best part was the in vivo data which showed that the mimic was just as effective as Neupogen at increasing neutrophil levels. The street's a bit slow on the pickup, but things are really cranking up on the science (and probably alliance) side. Not unexpectedly, just as the Business Week, NY Times, and Financial Times articles on diabetes and LGND were missed, so was the Science article on small molecule mimics.